Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells

Cytometry Part A

Volumn 83 A, Issue 1, 2013, Pages 114-126

  Park, Tea Soon ^a   Zimmerlin, Ludovic ^a   Zambidis, Elias T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Flow cytometry; Hematopoietic stem progenitor cells; Hemo vascular differentiation; Hemogenic endothelium; Human embryonic stem cells (hESC); Induced pluripotent stem cells (iPSC); Vascular progenitor cells

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN;

ARTICLE; BLOOD VESSEL; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CYTOLOGY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; STEM CELL; TIME LAPSE IMAGING;

ANTIGENS, CD34; ANTIGENS, CD45; BLOOD VESSELS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; STEM CELLS; TIME-LAPSE IMAGING;

EID: 84871659979     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22090     Document Type: Article

References (57)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
2. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R and others. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-20.
3. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-886.
4. Lengerke C, Daley GQ. Disease models from pluripotent stem cells. Annals of the New York Academy of Sciences 2009; 1176: 191-196.
5. Grskovic M, Javaherian A, Strulovici B, Daley GQ. Induced pluripotent stem cells-Opportunities for disease modelling and drug discovery. Nature reviews. Drug Discov 2011; 10: 915-929.
6. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012; 481: 295-305.
7. Niwa A, Umeda K, Chang H, Saito M, Okita K, Takahashi K, Nakagawa M, Yamanaka S, Nakahata T, Heike T. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors. J Cell Physiol 2009; 221: 367-77.
8. Zambidis ET, Sinka L, Tavian M, Jokubaitis V, Park TS, Simmons P, Peault B. Emergence of human angiohematopoietic cells in normal development and from cultured embryonic stem cells. Ann NY Acad Sci 2007; 1106: 223-232.
9. Zambidis ET, Peault B, Park TS, Bunz F, Civin CI. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005; 106: 860-870.
10. Zambidis ET, Park TS, Yu W, Tam A, Levine M, Yuan X, Pryzhkova M, Peault B. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008; 112: 3601-3614.
11. Jaffredo T, Gautier R, Eichmann A, Dieterlen-Lievre F. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development 1998; 125: 4575-4583.
12. Tavian M, Coulombel L, Luton D, Clemente HS, Dieterlen-Lievre F, Peault B. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood 1996; 87: 67-72.
13. de Bruijn MF, Ma X, Robin C, Ottersbach K, Sanchez MJ, Dzierzak E. Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity 2002; 16: 673-683.
14. Oberlin E, Tavian M, Blazsek I, Peault B. Blood-forming potential of vascular endothelium in the human embryo. Development 2002; 129: 4147-4157.
15. Park TS, Burridge P, E.T. Z. Chapter 24: Generation of Multipotent CD34+CD45+ Hematopoietic progenitors from human induced pluripotent stem cells. In: Marton PJ, editor. Lineage-Specific Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Springer Protocol Handbook, 2011.
16. Wang C, Tang X, Sun X, Miao Z, Lv Y, Yang Y, Zhang H, Zhang P, Liu Y, Du L and others. TGFbeta inhibition enhances the generation of hematopoietic progenitors from human ES cell-derived hemogenic endothelial cells using a stepwise strategy. Cell Res 2012; 22: 194-207.
17. Joo HJ, Kim H, Park SW, Cho HJ, Kim HS, Lim DS, Chung HM, Kim I, Han YM, Koh GY. Angiopoietin-1 promotes endothelial differentiation from embryonic stem cells and induced pluripotent stem cells. Blood 2011; 118: 2094-20104.
18. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS, Lanza R. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2009; 28: 704-712.
19. Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, Thomson J, Slukvin I. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009; 27: 559-567.
20. Melichar H, Li O, Ross J, Haber H, Cado D, Nolla H, Robey EA, Winoto A. Comparative study of hematopoietic differentiation between human embryonic stem cell lines. PLoS One 2011; 6: e19854.
21. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
22. Zimmerlin L, Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, Donnenberg VS. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011; 17: 93-106.
23. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B. Perivascular multipotent progenitor cells in human organs. Ann NY Acad Sci 2009; 1176: 118-123.
24. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481: 457-462.
25. Sroczynska P, Lancrin C, Kouskoff V, Lacaud G. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis. Blood 2009; 114: 5279-5289.
26. Friedman AD. Cell cycle and developmental control of hematopoiesis by Runx1. J Cell Physiol 2009; 219: 520-524.
27. Peault B, Tavian M. Hematopoietic stem cell emergence in the human embryo and fetus. Ann NY Acad Sci 2003; 996: 132-140.
28. Bollerot K, Pouget C, Jaffredo T. The embryonic origins of hematopoietic stem cells: A tale of hemangioblast and hemogenic endothelium. APMIS 2005; 113: 790-803.
29. Jaffredo T, Nottingham W, Liddiard K, Bollerot K, Pouget C, de Bruijn M. From hemangioblast to hematopoietic stem cell: an endothelial connection? Exp Hematol 2005; 33: 1029-1040.
30. Sinka L, Biasch K, Khazaal I, Peault B, Tavian M. Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo. Blood 2012; 119: 3712-3723.
31. Park TS, Zambidis ET. A role for the renin-angiotensin system in hematopoiesis. Haematologica 2009; 94: 745-747.
32. Jokubaitis VJ, Sinka L, Driessen R, Whitty G, Haylock DN, Bertoncello I, Smith I, Peault B, Tavian M, Simmons PJ. Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 2008; 111: 4055-4063.
33. Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin, II. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011; 117: e109-e119.
34. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ and others. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 2011; 13: 541-549.
35. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, Ng S, Sourour M, Hamalainen R, Olsson C and others. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471: 58-62.
36. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E and others. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471: 63-67.
37. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S and others. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471: 68-73.
38. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521-531.
39. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ and others. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011; 8: 106-118.
40. Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ, Williams DJ, Kahler DJ, Yamaki M, Davidow L and others. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011; 29: 279-286.
41. Rizzi R, Di Pasquale E, Portararo P, Papait R, Cattaneo P, Latronico MV, Altomare C, Sala L, Zaza A, Hirsch E and others. Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation. Cell Death Differ 2012; 19: 1162-1174.
42. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Hongguang H, Loh YH, Aryee MJ, Lensch MW, et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 2012; 29: 117-119.
43. Pfaff N, Lachmann N, Kohlscheen S, Sgodda M, Arauzo-Bravo MJ, Greber B, Kues W, Glage S, Baum C, Niemann H, et al. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells. Stem Cells Dev 2012; 21: 689-701.
44. Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 2011; 9: 17-23.
45. Quattrocelli M, Palazzolo G, Floris G, Schoffski P, Anastasia L, Orlacchio A, Vandendriessche T, Chuah MK, Cossu G, Verfaillie C, et al. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs. J Pathol 2011; 223: 593-603.
46. Vodyanik MA, Yu J, Zhang X, Tian S, Stewart R, Thomson JA, Slukvin, II. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell 2010; 7: 718-29.
47. Dar A, Domev H, Ben-Yosef O, Tzukerman M, Zeevi-Levin N, Novak A, Germanguz I, Amit M, Itskovitz-Eldor J. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 2012; 125: 87-99.
48. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009; 457: 892-895.
49. Eilken HM, Nishikawa S, Schroeder T. Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature 2009; 457: 896-900.
50. Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009; 206: 2483-2496.
51. Cossu G, Bianco P. Mesoangioblasts-Vascular progenitors for extravascular mesodermal tissues. Curr Opinion Genet Dev 2003; 13: 537-542.
52. Crisan M. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313.
53. Kopher RA, Penchev VR, Islam MS, Hill KL, Khosla S, Kaufman DS. Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells. Bone 2010; 47: 718-728.
54. Barbet R, Peiffer I, Hatzfeld A, Charbord P, Hatzfeld JA. Comparison of gene expression in human embryonic stem cells, hESC-derived mesenchymal stem cells and human mesenchymal stem cells. Stem Cells Int 2011; 2011: 368192.
55. Kaiser S, Hackanson B, Follo M, Mehlhorn A, Geiger K, Ihorst G, Kapp U. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype. Cytotherapy 2007; 9: 439-450.
56. Simmons DJ, Seitz P, Kidder L, Klein GL, Waeltz M, Gundberg CM, Tabuchi C, Yang C, Zhang RW. Partial characterization of rat marrow stromal cells. Calcified Tissue International 1991; 48: 326-334.
57. Zimmerlin L, Donnenberg VS, Donnenberg AD. Pericytes: A universal adult tissue stem cell? Cytometry Part A 2012; 81A: 12-14.